Are You Looking to Partner With Us?
Looking to maximise your influence in the next generation of cell engineering?
As RNA technologies explode onto the avenue of CTx engineering, the RNA CTx Summit is the only dedicated meeting gathering leading RNA and CTx developers who are looking to advance their pipelines to develop safe, functional and scalable CTx to market.
Our audience are seeking innovative solutions to advance their commercial growth by overcoming key challenges such as:
- Developing cell-specific delivery systems to accelerate scalable RNA expression
- Precision engineering to avoid off-target effects
- Analytical and process optimization to produce persistent and pure RNA
- Demonstrating safety and toxicity data to accelerate to approval
- Can you help? Let us know by contacting us here.
Why Partner With Us?
Generate new business leads with exclusive access to senior leadership from the leading RNA CTx companies, through structured networking and pre-organized 1-to-1 meetings
Demonstrate thought leadership to show your expertise directly to your target market to demonstrate your support of RNA CTx development
Benefit from market intelligence to discover what solutions biopharma companies need and match your solutions accordingly to drive brand awareness
Showcase Your Service or Products and spotlight your solutions such as raw material supplies, RNA characterization, LNP manufacturing and translational trial expertise to progress the RNA CTx field
For further information, don’t hesitate to contact us.
If you provide solutions to the RNA and CTx communities, you need to be at this meeting to establish your brand as the market's partner of choice. Reach out so that we can discuss the bespoke partnership opportunities available and maximize your commercial visibility.
Email sponsor@hansonwade.com to discuss your participation further.
“I connected with colleagues that I didn't know before and learned a lot about the current state of mRNA development/manufacturing and the existing pain points in the industry.” Marc Sauer, Chief Scientific Officer, BioVectra
“This event provides unmatched access to technological innovators and commercialization partners” Lael Cheung, Associate Director of Business Development, TriLink BioTechnologies
